Context Therapeutics Inc. is a biotechnology company focused on developing therapies for cancer treatment. The company is engaged in the research and development of novel drug candidates aimed at improving patient outcomes in oncology. It operates in the pharmaceutical sector, targeting various cancer indications and utilizing a range of therapeutic modalities. Context Therapeutics serves healthcare providers and patients primarily in the United States.
